Your browser doesn't support javascript.
loading
Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19.
Sakanashi, Daisuke; Asai, Nobuhiro; Nakamura, Akiko; Miyazaki, Narimi; Kawamoto, Yuzuka; Ohno, Tomoko; Yamada, Atsuko; Koita, Isao; Suematsu, Hiroyuki; Hagihara, Mao; Shiota, Arufumi; Kurumiya, Ai; Sakata, Miki; Kato, Syunji; Muramatsu, Yuki; Koizumi, Yusuke; Kishino, Takaaki; Ohashi, Wataru; Yamagishi, Yuka; Mikamo, Hiroshige.
Afiliação
  • Sakanashi D; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Asai N; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan; Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Japan.
  • Nakamura A; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Miyazaki N; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Kawamoto Y; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Ohno T; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Yamada A; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Koita I; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Suematsu H; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Hagihara M; Department of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Japan.
  • Shiota A; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Kurumiya A; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Sakata M; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Kato S; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Muramatsu Y; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan.
  • Koizumi Y; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan; Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Japan.
  • Kishino T; Department of Emergency and Critical Care Medicine, Aichi Medical University Hospital, Japan.
  • Ohashi W; Division of Biostatistics, Clinical Research Center, Aichi Medical University Hospital, Japan.
  • Yamagishi Y; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan; Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Japan.
  • Mikamo H; Department of Infection Control and Prevention, Aichi Medical University Hospital, Aichi, Japan; Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Japan. Electronic address: mikamo@aichi-med-u.ac.jp.
J Infect Chemother ; 27(1): 126-129, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33060046

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Saliva / RNA Viral / Nasofaringe / Infecções por Coronavirus / Betacoronavirus Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Saliva / RNA Viral / Nasofaringe / Infecções por Coronavirus / Betacoronavirus Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article